ArticleBMC cancer2018

Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance.

Katerina Pestova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.